ArticleJournal of gastrointestinal oncology2022

Efficacy and safety of camrelizumab in combination with trastuzumab and chemotherapy as the first-line treatment for patients with HER2-positive advanced gastric cancer.

Mengli Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.